Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

NCT01893359 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperopia
Hyperopic Astigmatism

Interventions

DRUG: riboflavin ophthalmic solution, 0% dextran
DEVICE: UVA Irradiation (30 mW/cm2 for 2 minutes continuous UVA)
DEVICE: UVA Irradiation (30 mW/cm2 for 3 minutes pulsed UVA with an on/off cycle of 2 seconds UVA on/1 second UVA off)
PROCEDURE: Laser-assisted in situ keratomileusis

Sponsor

Glaukos Corporation